0001179110-19-008532.txt : 20190708 0001179110-19-008532.hdr.sgml : 20190708 20190708165735 ACCESSION NUMBER: 0001179110-19-008532 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20190705 FILED AS OF DATE: 20190708 DATE AS OF CHANGE: 20190708 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Peoples Oliver P CENTRAL INDEX KEY: 0001377830 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-33133 FILM NUMBER: 19945776 MAIL ADDRESS: STREET 1: C/O METABOLIX, INC. STREET 2: 21 ERIE STREET CITY: CAMBRIDGE STATE: MA ZIP: 02139 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: YIELD10 BIOSCIENCE, INC. CENTRAL INDEX KEY: 0001121702 STANDARD INDUSTRIAL CLASSIFICATION: MISCELLANEOUS PLASTIC PRODUCTS [3080] IRS NUMBER: 043158289 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 201 CITY: WOBURN STATE: MA ZIP: 01801 BUSINESS PHONE: 617-583-1700 MAIL ADDRESS: STREET 1: 19 PRESIDENTIAL WAY STREET 2: SUITE 201 CITY: WOBURN STATE: MA ZIP: 01801 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX, INC. DATE OF NAME CHANGE: 20060717 FORMER COMPANY: FORMER CONFORMED NAME: METABOLIX INC DATE OF NAME CHANGE: 20000810 4 1 edgar.xml FORM 4 - X0306 4 2019-07-05 0 0001121702 YIELD10 BIOSCIENCE, INC. YTEN 0001377830 Peoples Oliver P C/O YIELD10 BIOSCIENCE, INC. 19 PRESIDENTIAL WAY WOBURN MA 01801 1 1 0 0 Pres & CEO Common Stock 2019-07-05 4 P 0 10000 .88 A 37628 D Common Stock 18246 I By 401(k) Plan These shares were purchased pursuant to a Rule 10b5-1 buying plan adopted by the reporting person on June 3, 2019. Represents the weighted average sales price for the shares purchased. Sales prices for this transaction ranged from $0.8620 to $0.8945. The reporting person undertakes to provide, upon request by the Securities and Exchange Commission staff, Yield10 Bioscience, Inc., or a security holder of Yield10 Bioscience, Inc., full information regarding the number of shares purchased at each separate price. These shares were acquired as Company matching contributions under the Yield10 Bioscience, Inc. 401(k) Plan. /s/ Megan N. Gates, attorney-in-fact 2019-07-08